• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,202.65
  • 0.66 %
  • $53.38
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Mangoceuticals, Inc. (MGRX) Stock Price, News & Analysis

Mangoceuticals, Inc. (MGRX) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.53

$0.06

(2.42%)

Day's range
$2.38
Day's range
$2.59
50-day range
$2.1
Day's range
$7.66
  • Country: US
  • ISIN: US56270V1061
52 wk range
$2.1
Day's range
$16.8


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -1.60
  • Piotroski Score 4.00
  • Grade N/A
  • Symbol (MGRX)
  • Company Mangoceuticals, Inc.
  • Price $2.53
  • Changes Percentage (2.42%)
  • Change $0.06
  • Day Low $2.38
  • Day High $2.59
  • Year High $16.80

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/15/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.44
  • Trailing P/E Ratio -0.98
  • Forward P/E Ratio -0.98
  • P/E Growth -0.98
  • Net Income $-9,212,417

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Mangoceuticals, Inc. Frequently Asked Questions

  • What is the Mangoceuticals, Inc. stock price today?

    Today's price of Mangoceuticals, Inc. is $2.53 — it has increased by +2.42% in the past 24 hours. Watch Mangoceuticals, Inc. stock price performance more closely on the chart.

  • Does Mangoceuticals, Inc. release reports?

    Yes, you can track Mangoceuticals, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Mangoceuticals, Inc. stock forecast?

    Watch the Mangoceuticals, Inc. chart and read a more detailed Mangoceuticals, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Mangoceuticals, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Mangoceuticals, Inc. stock ticker.

  • How to buy Mangoceuticals, Inc. stocks?

    Like other stocks, MGRX shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Mangoceuticals, Inc.'s EBITDA?

    Mangoceuticals, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Mangoceuticals, Inc.’s financial statements.

  • What is the Mangoceuticals, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -12.5939920136, which equates to approximately -1,259.40%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Mangoceuticals, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Mangoceuticals, Inc.'s financials relevant news, and technical analysis. Mangoceuticals, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Mangoceuticals, Inc. stock currently indicates a “sell” signal. For more insights, review Mangoceuticals, Inc.’s technical analysis.

  • A revenue figure for Mangoceuticals, Inc. for its last quarter?

    Mangoceuticals, Inc. published it's last quarterly revenues at $133,368.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.